Machine Learning Algorithms to Predict Recurrence within 10 Years after Breast Cancer Surgery: A Prospective Cohort Study.
Shi-Jer LouMing-Feng HouHong-Tai ChangSi-Un Frank ChiuHao-Hsien LeeShu-Chuan Jennifer YehHon-Yi ShiPublished in: Cancers (2020)
No studies have discussed machine learning algorithms to predict recurrence within 10 years after breast cancer surgery. This study purposed to compare the accuracy of forecasting models to predict recurrence within 10 years after breast cancer surgery and to identify significant predictors of recurrence. Registry data for breast cancer surgery patients were allocated to a training dataset (n = 798) for model development, a testing dataset (n = 171) for internal validation, and a validating dataset (n = 171) for external validation. Global sensitivity analysis was then performed to evaluate the significance of the selected predictors. Demographic characteristics, clinical characteristics, quality of care, and preoperative quality of life were significantly associated with recurrence within 10 years after breast cancer surgery (p < 0.05). Artificial neural networks had the highest prediction performance indices. Additionally, the surgeon volume was the best predictor of recurrence within 10 years after breast cancer surgery, followed by hospital volume and tumor stage. Accurate recurrence within 10 years prediction by machine learning algorithms may improve precision in managing patients after breast cancer surgery and improve understanding of risk factors for recurrence within 10 years after breast cancer surgery.
Keyphrases
- machine learning
- minimally invasive
- coronary artery bypass
- surgical site infection
- free survival
- end stage renal disease
- newly diagnosed
- healthcare
- chronic kidney disease
- artificial intelligence
- big data
- palliative care
- patients undergoing
- prognostic factors
- mass spectrometry
- acute coronary syndrome
- coronary artery disease
- patient reported outcomes
- peritoneal dialysis
- neural network
- breast cancer risk
- childhood cancer